Myles David C.

Insider·Olema Pharmaceuticals, Inc.·OLMA·Insider since 2025·Form 4 filings: 8
Trades YTD
5
Trades (12m)
8
Net position
Current holdings
P-code buys (12m)
0
Cluster
None

Transaction history · last 12 months

8 transactions
14 Jan 2026
SOLD
$OLMA
35,003
$28.99
S
14 Jan 2026
SOLD
$OLMA
14,997
$28.60
S
13 Jan 2026
SOLD
$OLMA
200
$28.49
S
13 Jan 2026
SOLD
$OLMA
49,800
$27.60
S
12 Jan 2026
SOLD
$OLMA
10,000
$28.34
S
19 Dec 2025
SOLD
$OLMA
6,046
$31.39
S
19 Dec 2025
SOLD
$OLMA
43,729
$30.40
S
19 Dec 2025
SOLD
$OLMA
1,225
$28.08
S

Transaction codes: P open-market purchase · S sale · M option exercise · A grant.

Cluster context · Olema Pharmaceuticals, Inc.

last 30 days

No active insider cluster at Olema Pharmaceuticals, Inc. in the last 30 days. C.'s recent transactions appear in the section above.

Convergence · Pattern Engine ships in v1.1

30-day window
In development

Convergence participation lands with the Pattern Engine.

Once the Pattern Engine ships, this section will list every active convergence event C. is named in — the hedge funds and Congress members on the same name, the 30-day window, and the combined position size.

Context

Form 4 background

Form 4 filings are required within two business days of any insider transaction by an officer, director, or 10%+ shareholder. Open-market purchases (transaction code P) are the most signal-rich because they indicate the insider is paying market price with personal cash — as distinct from option exercises, scheduled sales, or compensation grants. Cluster buying — three or more insiders of the same company buying open-market shares in a 30-day window — has historically been one of the strongest positive insider-trading signals in the academic literature.

Source data: SEC EDGAR · Form 4 filings · Last refreshed 12:17 UTC.